In human cells, telomerase activity is regulated by transcriptional control
of the telomerase reverse transcriptase gene (hTERT) whose product is the
catalytic subunit of the enzyme. The hTERT promoter is active in virtually
all types of tumors and immortal cells. but is silent in most adult somatic
tissues, in this study, we placed the herpes simplex virus thymidine kinas
e gene under the control of the hTERT promoter with the aim of restricting
its expression to tumor cells. In transfection experiments, the hTERT promo
ter driven thymidine kinase gene (hTERTp/TK) conferred ganciclovir sensitiv
ity to all tumor and immortal cell lines tested. whereas normal somatic cel
ls remained largely unaffected. Human hTERTp/TK-positive cancer cells impla
nted in nude mice developed into tumors that could be eradicated by gancicl
ovir treatment. The hTERTp/TK cassette was inserted into an adenovirus vect
or and its efficacy in reducing tumor growth was compared with that of an a
denovirus carrying the thymidine kinase gene under the control of the cytom
egalovirus immediate-early promoter (CMVp/TK). In a xeno-graft model using
the human 143B osteosarcoma cell line, a single injection of either virus r
esulted in equivalent tumor regression and survival upon ganciclovir treatm
ent In animals injected intratumorally with the CMVp/TK adenovirus, express
ion of the thymidine kinase gene was detected in tumors, as well as in live
r samples. Expression of the suicide gene in combination with ganciclovir r
esulted in severe liver histopathology and in an elevation of hepatic enzym
es. In sharp contrast, when the hTERT promoter controlled the thymidine kin
ase gene, transgene expression was observed in tumors, but not in liver sam
ples. Normal liver function in these animals was confirmed by serum levels
of hepatic enzymes that were indistinguishable from those of control health
y mice. These results indicate that by restricting thymidine kinase express
ion to tumor cells, the hTERT promoter allows the tumoricidal effect of the
suicidal gene to be exerted without detrimental consequences on healthy ti
ssues and vital organs. The tight specificity of expression imparted by the
hTERT promoter will assist the development of novel approaches to the trea
tment of a broad array of cancer types.